Related Experiment Video

Updated: Jun 12, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.6K

The Role of CDCA2 in tumor genesis, prognosis and future treatments

Xinyi Lin1, Zijian Zou1, Jingqin Zhong1

  • 1Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

European Journal of Cancer (Oxford, England : 1990)
|September 17, 2024
PubMed

Insights

The Cell Division Cycle Associated 2 (CDCA2) protein is crucial for cell division and DNA repair. Elevated CDCA2 levels are linked to poor cancer prognosis, highlighting its potential as a diagnostic biomarker and therapeutic target.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Cell Division Cycle Associated 2 (CDCA2) gene encodes a protein vital for cell cycle progression.
  • CDCA2 participates in critical cellular functions including chromosome segregation, DNA repair, and microtubule dynamics.

Purpose of the Study:

  • To explore the multifaceted roles of CDCA2 in cellular processes.
  • To investigate the association between CDCA2 expression and cancer prognosis.
  • To evaluate CDCA2 as a potential biomarker and therapeutic target in oncology.

Main Methods:

  • Literature review of studies investigating CDCA2 function and expression.
  • Analysis of correlations between CDCA2 levels and clinicopathological features in various cancers.

Main Results:

  • CDCA2 is implicated in chromosome segregation, nuclear envelope reassembly, and DNA damage response.
  • Elevated CDCA2 expression correlates with poor prognosis and advanced TNM stage in multiple cancer types.
  • CDCA2 is involved in key signaling pathways, including PI3K/Akt and p53.

Conclusions:

  • CDCA2 plays a significant role in cell division and cancer progression.
  • CDCA2 represents a promising biomarker for cancer diagnosis and a potential target for novel cancer therapies, including targeted therapy and immunotherapy.
Keywords:
BiomarkerCancerCancer treatmentCell Division Cycle Associated 2MitosisSignaling pathway

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.1K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

13.7K

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K